Proceedings from the 2nd Next Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3-4, 2019Scott Canna, Vincent Del Gaizo, Jonathan Boutelle et al.|Pediatric Rheumatology|2020Cited by 21
A44: High Levels of DEK Autoantibodies May Predict Early Flare Following Cessation of Anti‐TNF TherapyNirit Mor‐Vaknin, David M. Markovitz, Miguel Rivas et al.|Arthritis & Rheumatology|2014Cited by 1
A20: Understanding the Use and Biology of TNF Therapy in JIA—Clinical OutcomesDaniel J. Lovell, Edward H. Giannini, Anne Johnson et al.|Arthritis & Rheumatology|2014Cited by 1
Understanding the biology and use of TNF therapy in jia-clinical outcomesDaniel J. Lovell, Edward H. Giannini, Anne Johnson et al.|Pediatric Rheumatology|2014Cited by 0